Cargando…
Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations
Studies of pharmacogenomics-related traits are increasingly being performed to identify loci that affect either drug response or susceptibility to adverse drug reactions. However, the effect of the polymorphisms can differ in magnitude or be absent depending on the population being assessed. We used...
Autores principales: | Bonifaz-Peña, Vania, Contreras, Alejandra V., Struchiner, Claudio Jose, Roela, Rosimeire A., Furuya-Mazzotti, Tatiane K., Chammas, Roger, Rangel-Escareño, Claudia, Uribe-Figueroa, Laura, Gómez-Vázquez, María José, McLeod, Howard L., Hidalgo-Miranda, Alfredo, Parra, Esteban J., Fernández-López, Juan Carlos, Suarez-Kurtz, Guilherme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242606/ https://www.ncbi.nlm.nih.gov/pubmed/25419701 http://dx.doi.org/10.1371/journal.pone.0112640 |
Ejemplares similares
-
Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2012) -
Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2014) -
A Comparison of Association Methods for Cytotoxicity Mapping in Pharmacogenomics
por: Brown, Chad, et al.
Publicado: (2011) -
Correction: Exploring the Distribution of Genetic Markers of Pharmacogenomics Relevance in Brazilian and Mexican Populations
Publicado: (2015) -
Identification of ancestry proportions in admixed groups across the Americas using clinical pharmacogenomic SNP panels
por: Debortoli, Guilherme, et al.
Publicado: (2021)